These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30900485)

  • 1. Recent advances in the molecular landscape of lung neuroendocrine tumors.
    Pelosi G; Bianchi F; Hofman P; Pattini L; Ströbel P; Calabrese F; Naheed S; Holden C; Cave J; Bohnenberger H; Dinter H; Harari S; Albini A; Sonzogni A; Papotti M; Volante M; Ottensmeier CH
    Expert Rev Mol Diagn; 2019 Apr; 19(4):281-297. PubMed ID: 30900485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and molecular classification of lung neuroendocrine neoplasms.
    Metovic J; Barella M; Bianchi F; Hofman P; Hofman V; Remmelink M; Kern I; Carvalho L; Pattini L; Sonzogni A; Veronesi G; Harari S; Forest F; Papotti M; Pelosi G
    Virchows Arch; 2021 Jan; 478(1):5-19. PubMed ID: 33474631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.
    Pelosi G; Papotti M; Rindi G; Scarpa A
    Endocr Pathol; 2014 Jun; 25(2):151-64. PubMed ID: 24771462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and current controversies in lung neuroendocrine neoplasms
    Metovic J; Bianchi F; Rossi G; Barella M; Sonzogni A; Harari S; Papotti M; Pelosi G
    Semin Diagn Pathol; 2021 Sep; 38(5):90-97. PubMed ID: 33810912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.
    Pelosi G; Bianchi F; Dama E; Simbolo M; Mafficini A; Sonzogni A; Pilotto S; Harari S; Papotti M; Volante M; Fontanini G; Mastracci L; Albini A; Bria E; Calabrese F; Scarpa A
    Virchows Arch; 2018 Apr; 472(4):567-577. PubMed ID: 29388013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
    Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
    APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
    Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
    Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
    Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations of neuroendocrine tumours of the lung.
    Rossi G; Bertero L; Marchiò C; Papotti M
    Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.
    Fernandez-Cuesta L; Sexton-Oates A; Bayat L; Foll M; Lau SCM; Leal T
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e390794. PubMed ID: 37229617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of tumor PD-L1 (CD274) expression with lower mortality in lung high-grade neuroendocrine tumor.
    Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Nishio M; Okumura S; Ishikawa Y
    Cancer Med; 2017 Oct; 6(10):2347-2356. PubMed ID: 28925087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of lung neuroendocrine neoplasm classification.
    Metovic J; Barella M; Harari S; Pattini L; Albini A; Sonzogni A; Veronesi G; Papotti M; Pelosi G
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):377-387. PubMed ID: 33306420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?
    Volante M; Mete O; Pelosi G; Roden AC; Speel EJM; Uccella S
    Endocr Pathol; 2021 Mar; 32(1):154-168. PubMed ID: 33641055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.